Related Experiment Videos

Dantrolene: effects on abnormal intracellular Ca(2+) handling and inotropy in postinfarcted rat myocardium

Jiang-Yong Min1, Achim Meissner, Xin Feng

  • 1Cardiovascular Division, Beth Israel Deaconess Medical Center, and Harvard Medical School, Boston, MA 02215, USA.

Insights

Dantrolene treatment in rats with myocardial infarction improved heart muscle function by enhancing calcium handling. This intervention lowered diastolic calcium levels and improved the response to beta-adrenoceptor stimulation.

Area of Science:

  • Cardiology
  • Pharmacology
  • Physiology

Background:

  • Myocardial infarction (MI) leads to impaired cardiac function.
  • Altered intracellular calcium ([Ca2+]i) handling is a key feature of post-MI hearts.
  • Therapeutic strategies to improve calcium handling are crucial for post-MI recovery.

Purpose of the Study:

  • To investigate the effects of dantrolene on intracellular calcium handling and inotropy in a rat model of myocardial infarction.
  • To determine if dantrolene can ameliorate cardiac dysfunction following infarction.

Main Methods:

  • Rats with induced myocardial infarction were divided into dantrolene-treated groups and a placebo control group.
  • Isometric contractility and intracellular calcium transients were measured in isolated papillary muscles.
  • Protein levels of sarcoplasmic reticulum Ca2+ ATPase were analyzed.

Main Results:

  • Dantrolene treatment significantly reduced diastolic intracellular calcium ([Ca2+]i) in infarcted rat myocardium.
  • The inotropic response to isoproterenol was significantly improved in dantrolene-treated infarcted rats.
  • Protein levels of sarcoplasmic reticulum Ca2+ ATPase were elevated following dantrolene treatment.

Conclusions:

  • Dantrolene improves the inotropic response to beta-adrenoceptor stimulation in post-infarcted rat myocardium.
  • Enhanced intracellular calcium handling, including lowered diastolic [Ca2+]i, underlies dantrolene's beneficial effects.
  • Dantrolene represents a potential therapeutic agent for managing cardiac dysfunction after myocardial infarction.

Related Concept Videos